Angelo Matturro studied Pharmaceutical Chemistry and Technologies at the University of Salerno (Italy). After experience in Genetic spa gained in 5y with focus on development equivalent drugs working with different dosage forms in ophthalmic and inhalation therapeutic area, Angelo joined […]

Dr. Gur Jai Pal Singh is the Chief Scientific Advisor at BBSG Pharm Associates since June 2023. Before that he served as a Senior VP and headed a Pharma Company’s Respiratory Centre of Excellence – providing end-to-end hand-on leadership for […]

Jag Shur is a pioneering researcher and entrepreneur. He is currently CTO at RIGImmune Inc, a clinical stage biotech developing advanced nucleic acid treatments for respiratory medicine. Shur holds a Ph.D. in Inhaled Biopharmaceutics: Drug Delivery to the Cystic Fibrosis […]

Mary McElroy has worked in lung discovery and safety assessment for over 25 years. At Charles River, Mary combines her current role as Head of the Discovery Pharmacology and Toxicology with previous roles as an inhalation toxicologist and academic group […]

Dr Io Hui is a registered Chartered Engineer (CEng), and a visiting researcher at the Allergy and Respiratory Research Group, The University of Edinburgh. She has extensive industrial and academic experience in leading digital health development and implementation, technological expertise […]

Kalpita Nadkar is a seasoned pharmaceutical drug product and process development professional, specializing in niche dosage forms like Pressurized Metered Dose Inhalers (pMDIs), Lyophilized drug products and CAR-T cell therapy operations. With a Master of Science in Pharmaceutical Sciences from […]

Dr. Peter Wirthschaft has over 15 years of experience in R&D, regulatory affairs, marketing, sales, and business development in the medical devices and services sector. As a Senior Managing Consultant at NSF, he leads the practices in in-vitro diagnostics, drug-device […]

Joschka T. Müller is a licensed pharmacist in Germany since 2022 and a fourth-year PhD candidate at LMU Munich. His research in Prof. Dr. Olivia Merkel’s lab focuses on developing siRNA polyplex therapies targeting human betacoronaviruses, addressing challenges in pulmonary […]

Mr. Hansal has done Master’s of Pharmacy (Regulatory Affairs) and has more than 6 years of experience in the regulatory affairs. He is working as Associate Manager with Pfizer Healthcare. Earlier he has been associated with Jamp Pharma, Intas and […]

Carola Fuchs, PhD, leads the e-Health department at PARI and is responsible for development, lifecycle management, business development and management of all e-Health activities for the PARI Group. She joined PARI after working for Sanofi and a biotech start-up in […]